Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Accelerated Approval: US FDA Defends Size Of Premarket Safety Databases, Confirmatory Endpoints

Mar 05 2018

• By Sue Sutter

Medical book with Stethoscope

Related Content

Mylotarg Returns: US FDA Approves Pfizer's Leukemia Drug With Bonus Pediatric Indication

Sep 04 2017

JAMA Study Continues Wave Of Accelerated Approval Criticism Amid Expansion Of Pathway

Aug 28 2017

NEJM Takes Aim At Expensive Accelerated Approval Drugs Amid Congressional Drug Pricing Debate

May 25 2017

Safety Events For Accelerated Approval Drugs Highlighted As Expansion Looms

May 14 2017

Pfizer Pulls Mylotarg For Safety 10 Years After Accelerated Approval

Jun 28 2010

Related Companies

Pfizer Inc.

Additional Topics

United States Drug Approval Standards Review Pathway Regulation Cancer BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window